Central Maine Imaging Center is proud to announce our investment in “Dynacad”. Dynacad stands for dynamic computer assisted detection and assists radiologists in the analysis of breast MRI.

This technological advance not only aids radiologists in the detection of breast lesions, but also assists in determining if these lesions are benign or suspicious and would warrant biopsy. The advances of Dynacad can potentially save patients from undergoing unnecessary biopsy procedures.

A Breast MRI exam at CMIC takes approximately 45 minutes to complete. The patient is administered an injection of gadolinium during the procedure. Gadolinium is a contrast agent used to enhance potential breast lesions. Breast MRI images are then interpreted by the radiologists using Dynacad. Depending on how the breast lesion absorbs the gadolinium and how it is translated through Dynacad, it can assist in denoting if the lesion is benign or suspicious.

If you have any of the below criteria, please speak with your medical provider to review your personal options.

• If the patient has been diagnosed with having the BRCA1 or BRCA2 mutation.
• If the patient has a first- degree family member (sibling, child or parent) with a BRCA1 or BRCA2 mutation, even if the patient has not been tested to date.
• If the patient has a lifetime risk that has been scored by their provider at 20-25% or greater, predicated on one of the several accepted risk assessment tools that review family history.

If you have questions or would like more information about Breast MRI at CMIC, please call (207) 795-2030.